Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease
dc.contributor.author | Zimran, A. | |
dc.contributor.author | Durán Saavedra, Gloria Patricia | |
dc.contributor.author | Giraldo, P. | |
dc.contributor.author | Rosenbaum, H. | |
dc.contributor.author | Giona, F. | |
dc.contributor.author | Petakov, M. | |
dc.contributor.author | Munoz, E.T. | |
dc.contributor.author | Solorio-Meza, S.E. | |
dc.contributor.author | Cooper, P.A. | |
dc.contributor.author | Varughese, S. | |
dc.contributor.author | Alon, S. | |
dc.contributor.author | Chertkoff, R. | |
dc.date.accessioned | 2020-10-28T14:12:12Z | |
dc.date.available | 2020-10-28T14:12:12Z | |
dc.date.issued | 2019 | |
dc.format.extent | 8 páginas | |
dc.fuente.origen | Converis | |
dc.identifier.doi | 10.1016/j.bcmd.2016.07.002 | |
dc.identifier.issn | 1079-9796 | |
dc.identifier.issn | 1096-0961 | |
dc.identifier.uri | https://doi.org/10.1016/j.bcmd.2016.07.002 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/48162 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido completo | |
dc.pagina.final | 21 | |
dc.pagina.inicio | 14 | |
dc.revista | Blood Cells, Molecules and Diseases | es_ES |
dc.rights | acceso abierto | |
dc.subject | Gaucher disease | es_ES |
dc.subject | Enzyme replacement therapy | es_ES |
dc.subject | Taliglucerase alfa | es_ES |
dc.subject | Splenomegaly | es_ES |
dc.subject | Hepatomegaly | es_ES |
dc.subject | Anemia | es_ES |
dc.subject | Thrombocytopenia | es_ES |
dc.subject | Chitotriosidase | es_ES |
dc.subject | Chemokine (CC motif) ligand 18 | es_ES |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.subject.other | Terapia de reemplazo de enzimas | es_ES |
dc.subject.other | Enfermedad de Gaucher | es_ES |
dc.subject.other | Anemia | es_ES |
dc.subject.other | Glucosilceramidasa | es_ES |
dc.subject.other | Proteínas recombinantes | es_ES |
dc.title | Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease | es_ES |
dc.type | artículo | |
dc.volumen | Vol. 78 | |
sipa.codpersvinculados | 1001949 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease.pdf
- Size:
- 1.25 MB
- Format:
- Adobe Portable Document Format
- Description: